Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription

Kidney International

Volumn 86, Issue 6, 2014, Pages 1106-1115

  Meir, Tomer ^a   Durlacher, Karina ^a   Pan, Zheng ^b   Amir, Gail ^a   Richards, William G ^b   Silver, Justin ^a   Naveh Many, Tally ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b AMGEN INC   (United States)

Author keywords

Calcium sensing receptor; Chronic kidney failure; FGF23; Parathyroid hormone

Indexed keywords

CALCIMIMETIC AGENT; CALCIUM; CREATININE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DACTINOMYCIN; FIBROBLAST GROWTH FACTOR 23; MESSENGER RNA; NUCLEAR RECEPTOR RELATED FACTOR 1; ORPHAN NUCLEAR RECEPTOR; PARATHYROID HORMONE; PHOSPHATE; SHORT HAIRPIN RNA; TECALCET;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING SITE; CALVARIA; CHROMATIN IMMUNOPRECIPITATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMUR; GENE INSERTION SEQUENCE; GENE MAPPING; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSCRIPTION INITIATION SITE; UREMIA; WESTERN BLOTTING;

EID: 84964267910     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.215     Document Type: Article

References (52)

1. Hu MC, Shiizaki K, Kuro-o M et al. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism.. Annu Rev Physiol 2013; 75: 503-533.
2. Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435.
3. Saito H, Kusano K, Kinosaki M et al. Human fibroblast growth factor-23 mutants suppress Na-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 2003; 278: 2206-2211.
4. Nakatani T, Sarraj B, Ohnishi M et al. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis. FASEB J 2009; 23: 433-441.
5. Ben Dov IZ, Galitzer H, Lavi-Moshayoff V et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007; 117: 4003-4008.
6. Krajisnik T, Bjorklund P, Marsell R et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125-131.
7. Galitzer H, Ben Dov IZ, Silver J et al. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010; 77: 211-218.
8. Canalejo R, Canalejo A, Martinez-Moreno JM et al. FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 2010; 21: 1125-1135.
9. Komaba H, Goto S, Fujii H et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2010; 77: 232-238.
10. Kulkarni NH, Halladay DL, Miles RR et al. Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem 2005; 95: 1178-1190.
11. Maeda A, Okazaki M, Baron DM et al. Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH. PNAS 2013; 110: 5864-5869.
12. Jean G, Terrat JC, Vanel T et al. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. Nephrol Dial Transplant 2009; 24: 2792-2796.
13. Isakova T, Xie HL, Yang W et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305: 2432-2439.
14. Lavi-Moshayoff V, Wasserman G, Meir T et al. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: A bone parathyroid feedback loop. Am J Physiol Renal Physiol 2010; 299: F882-F889.
15. Koizumi M, Komaba H, Nakanishi S et al. Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. Nephrol Dial Transplant 2012; 27: 784-790.
16. Wang Z, Benoit G, Liu J et al. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 2003; 423: 555-560.
17. Maruyama K, Tsukada T, Ohkura N et al. The NGFI-B subfamily of the nuclear receptor superfamily (review). Int J Oncol 1998; 12: 1237-1243.
18. Tetradis S, Bezouglaia O, Tsingotjidou A. Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells. Endocrinology 2001; 142: 663-670.
19. Lammi J, Huppunen J, Aarnisalo P. Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts. Mol Endocrinol 2004; 18: 1546-1557.
20. Pirih FQ, Tang A, Ozkurt IC et al. Nuclear orphan receptor Nurr1 directly transactivates the osteocalcin gene in osteoblasts. J Biol Chem 2004; 279: 53167-53174.
21. Pirih FQ, Aghaloo TL, Bezouglaia O et al. Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo. Biochem Biophys Res Commun 2005; 332: 494-503.
22. Wilson TE, Fahrner TJ, Johnston M et al. Identification of the Dna-binding site for NGFI-B by genetic selection in yeast. Science 1991; 252: 1296-1300.
23. Perlmann T, Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 1995; 9: 769-782.
24. Zetterstrom RH, Solomin L, Jansson L et al. Dopamine neuron agenesis in Nurr1-deficient mice. Science 1997; 276: 248-250.
25. Vuillermot S, Joodmardi E, Perlmann T et al. Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency. Genes Brain Behav 2011; 10: 589-603.
26. Liu SG, Tang W, Fang JW et al. Novel regulators of Fgf23 expression and mineralization in Hyp bone. Mol Endocrinol 2009; 23: 1505-1518.
27. Fu YT, Frith MC, Haverty PM et al. MotifViz: An analysis and visualization tool for motif discovery. Nucl Acids Res 2004; 32: W420-W423.
28. Portales-Casamar E, Arenillas D, Lim J et al. The PAZAR database of gene regulatory information coupled to the ORCA toolkit for the study of regulatory sequences. Nucl Acids Res 2009; 37: D54-D60.
29. Levi R, Ben Dov IZ, Lavi-Moshayoff V et al. Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol 2006; 17: 107-112.
30. Westerberg PA, Linde T, Wikstrom B et al. Regulation of fibroblast growth factor-23 in chronic kidney disease. Nephrol Dial Transplant 2007; 22: 3202-3207.
31. Isakova T, Wahl P, Vargas GS et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 2011; 79: 1370-1378.
32. Burnett-Bowie SA, Henao MP, Dere ME et al. Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men. J Bone Min Res 2009; 24: 1681-1685.
33. Liu S, Tang W, Zhou J et al. Fibroblast growth factor 23 is a counterregulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 2006; 17: 1305-1315.
34. Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007; 40: 1434-1446.
35. Lee M, Partridge NC. Parathyroid hormone signaling in bone and kidney. Curr Opin Nephrol Hypertens 2009; 18: 298-302.
36. Christov M, Waikar SS, Pereira RC et al. Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney Int 2013; 84: 776-785.
37. Powell WF, Barry KJ, Tulum I et al. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J Endocrinol 2011; 209: 21-32.
38. Hoke TS, Douglas IS, Klein CL et al. Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol 2007; 18: 155-164.
39. Silver J, Naveh-Many T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat Rev Nephrol 2013; 9: 641-649.
40. Krieger NS, Culbertson CD, Kyker-Snowman K et al. Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone. Am J Physiol Renal Physiol 2012; 303: F431-F436.
41. Shimada T, Yamazaki Y, Takahashi M et al. Vitamin D receptorindependent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol 2005; 289: F1088-F1095.
42. Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JR et al. Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 2012; 23: 1190-1197.
43. Kolek OI, Hines ER, Jones MD et al. 1alpha,25-dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 2005; 289: G1036-G1042.
44. Farrow EG, Yu XJ, Summers LJ et al. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci USA 2011; 108: E1146-E1155.
45. Wolf M, Koch TA, Bregman DB. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Min Res 2013; 28: 1793-1803.
46. Saini RK, Kaneko I, Jurutka PW et al. 1,25-dihydroxyvitamin D-3 regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-Calcif Tissue Int 2013; 92: 339-353.
47. Martin A, Liu S, David V et al. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J 2011; 25: 2551-2562.
48. Hurley MM, Tetradis S, Huang YF et al. Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Min Res 1999; 14: 776-783.
49. Hu MC, Shi MJ, Zhang JN et al. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int 2010; 78: 1240-1251.
50. Troshin PV, Procter JB, Barton GJ. Java bioinformatics analysis web services for multiple sequence alignment-JABAWS:MSA. Bioinformatics 2011; 27: 2001-2002.
51. Woronicz JD, Lina A, Calnan BJ et al. Regulation of the Nur77 orphan steroid-receptor in activation-induced apoptosis. Mol Cell Biol 1995; 15: 6364-6376.
52. Bryne JC, Valen E, Tang MHE et al. JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucl Acids Res 2008; 36: D102-D106.